[Previous Months][Date Index][Thread Index][Join - Register][Login]   Help@Insulin-Pumpers.org
  [Message Prev][Message Next][Thread Prev][Thread Next]   for subscribe/unsubscribe assistance
 
 

[IP] Insulin pump therapy in children and adolescents (Australia)



http://www.blackwell-synergy.com/links/doi/10.1111/j.1464-5491.2004.01359.x/a
b
s

Diabetic Medicine
Volume 22 Issue 1 Page 92  - January 2005
doi:10.1111/j.1464-5491.2004.01359.x


Insulin pump therapy in children and adolescents: improvements in key
parameters of diabetes management including quality of life
S. K. McMahon*, F. L. Airey*, D. A. Marangou*, K. J. McElwee*, C. L. Carne*,
A. J. Clarey*, E. A. Davis* and T. W. Jones*

 Abstract

Aims  To determine the impact of insulin pump therapy (continuous
subcutaneous insulin infusion) on key parameters of diabetes management
including quality
of life in children and adolescents with Type 1 diabetes mellitus (T1DM).
Methods  All patients started on insulin pump therapy were prospectively
followed before and after institution of insulin pump therapy. Data collected
included age, duration of diabetes, glycated haemoglobin levels (HbA1c),
anthropometric data and episodes of severe hypoglycaemia defined as
hypoglycaemia
resulting in coma or convulsion. A subset of patients also completed the
Diabetes
Quality of Life Instrument (DQOL) and Self-Efficacy for Diabetes Scale (SED)
questionnaires to assess quality of life.
Results  At the time of analysis, 100 patients had been managed with insulin
pump therapy. The mean age when starting pump therapy was 12.5 (3.919.6)
years. Duration of therapy ranged from 0.2 to 4.0 years (mean 1.4 years,
median 1.5
years). HbA1c decreased from 8.3 1 0.1% prior to pump therapy to 7.8 1 0.1%
(P
.
----------------------------------------------------------
for HELP or to subscribe/unsubscribe/change list versions,
contact: HELP@insulin-pumpers.org